Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:01 UTC |
---|
HMDB ID | HMDB0015527 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Prazepam |
---|
Description | Prazepam, also known as demetrin or centrax, belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. Prazepam is a drug which is used for the treatment of anxiety disorders. Prazepam is a strong basic compound (based on its pKa). Prazepam is a potentially toxic compound. Abrupt or over-rapid discontinuation of prazepam after long-term use, even at low dosage, may result in a protracted withdrawal syndrome. Side effects of prazepam are less profound than with other benzodiazepines. Benzodiazepines require special precaution if used in the elderly, during pregnancy, in children, alcohol or drug-dependent individuals and individuals with comorbid psychiatric disorders. Animal studies have found prazepam taken during pregnancy results in delayed growth and causes reproductive abnormalities. |
---|
Structure | ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1 InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2 |
---|
Synonyms | Value | Source |
---|
Centrax | Kegg | Parke davis brand OF prazepam | HMDB | Warner-lambert brand OF prazepam | HMDB | Demetrin | HMDB | Pfizer brand OF prazepam | HMDB | Reapam | HMDB | Lysanxia | HMDB | mono Demetrin | HMDB | United drug brand OF prazepam | HMDB |
|
---|
Chemical Formula | C19H17ClN2O |
---|
Average Molecular Weight | 324.804 |
---|
Monoisotopic Molecular Weight | 324.102940883 |
---|
IUPAC Name | 7-chloro-1-(cyclopropylmethyl)-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
---|
Traditional Name | prazepam |
---|
CAS Registry Number | 2955-38-6 |
---|
SMILES | ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2 |
---|
InChI Key | MWQCHHACWWAQLJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Tertiary carboxylic acid amide
- Carboxamide group
- Ketimine
- Lactam
- Carboxylic acid derivative
- Azacycle
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic oxygen compound
- Imine
- Organic nitrogen compound
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 145 - 146 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.004 g/L | Not Available | LogP | 3.73 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 174.0 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Prazepam GC-MS (Non-derivatized) - 70eV, Positive | splash10-002e-3090000000-85ecde8de7c9923c1afc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Prazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Prazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-00r5-3391000000-0113e86cca51d223d412 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Prazepam 35V, Positive-QTOF | splash10-00b9-0098000000-121cdb4df09299b2a55f | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 10V, Positive-QTOF | splash10-056r-5009000000-0f619abd238690bf909e | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 20V, Positive-QTOF | splash10-0a4i-9022000000-7d0f4b34a0dc683c936a | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 40V, Positive-QTOF | splash10-0a4i-9000000000-7386d4be3880cf54c894 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 10V, Negative-QTOF | splash10-00di-0029000000-d01af5072c81e6d91456 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 20V, Negative-QTOF | splash10-00xr-1097000000-243b0ed20eedd8c76c72 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 40V, Negative-QTOF | splash10-0006-9460000000-91a4eb6554df563a3898 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 10V, Positive-QTOF | splash10-004i-0009000000-db9fa6607403d494beac | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 20V, Positive-QTOF | splash10-0032-0094000000-cc4f8e8cd82551329624 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 40V, Positive-QTOF | splash10-05n3-4190000000-fa9f154eaa14bdf4214a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 10V, Negative-QTOF | splash10-00di-0009000000-33c2d52f8e6510237ee4 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 20V, Negative-QTOF | splash10-00yi-3095000000-d45edb96f10dbdf7642e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Prazepam 40V, Negative-QTOF | splash10-001i-9070000000-47517480edb6242ad95f | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|